Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 07/05/2026

    MRI is a better indicator than BMI of when body fat becomes dangerous

    MRI analysis of fat and muscle distribution in more than 66,000 people provides a more accurate assessment of health risks / Poor muscle quality poses an additional risk / Study provides reference values based on age, sex, and height

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-better-indicator-bmi-when-body-fat-becomes-dangerous
  • Press release - 06/05/2026

    International Symposium "Frontiers in Skin Immunity" brings leading immunologists to Heidelberg

    From May 15–16, 2026, the 3rd International Symposium “Frontiers in Skin Immunity” will bring leading experts in dermatology and immunology to Heidelberg. Organized by the SFB Transregio 156 “The Skin as Sensor and Initiator of Local and Systemic Immunity” and the Medical Faculty of Heidelberg University the meeting highlights advances in understanding skin immune responses and marks the conclusion of the consortium’s third funding period.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-symposium-frontiers-skin-immunity-brings-leading-immunologists-heidelberg
  • Press release - 04/05/2026

    Recommendation for Better Protection: Outdoor Workers Particularly Vulnerable to Melanoma, Study Finds

    As the sun rises higher in the sky this spring, UV exposure increases. This should be addressed with proper sun protection. New data shows that people who work outdoors frequently are at a significantly higher risk of developing melanoma on their faces. At the same time, many affected individuals lack awareness of the risks and fail to use systematic sun protection.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/recommendation-better-protection-outdoor-workers-particularly-vulnerable-melanoma-study-finds
  • Press release - 04/05/2026

    How personalised is healthcare?

    This year’s Health Congress at Furtwangen University (HFU) focused on the timely topic of personalised healthcare. With the theme “Health for EVERYONE! – Successful Strategies Through personalised Healthcare,” HFU hosted the event for the 15th time in collaboration with the Black Forest-Baar Health Network, the Furtwangen University Support Association PRO HFU e.V., and the City of Furtwangen.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-personalised-healthcare
  • Press release - 30/04/2026

    Award for outstanding studies in cancer research

    Her ground-breaking research studies on the regulation of gene activity have earned Dr Angelika Feldmann the Hella Bühler Prize for 2026, which is endowed with 100,000 euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-outstanding-studies-cancer-research
  • Press release - 30/04/2026

    A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

    Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (USA), an international research team has evaluated a novel approach for the diagnosis of pulmonary tuberculosis. The method enables detection of Mycobacterium tuberculosis without laboratory infrastructure, within a markedly shorter time frame than conventional diagnostics, and using a simple swab.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/single-swab-sufficient-study-paves-way-simplified-tuberculosis-diagnosis
  • Press release - 30/04/2026

    Ulm University honours early-career researchers Awards ceremony at Villa Eberhardt

    Ulm University held an awards ceremony to recognise the outstanding achievements in research and teaching of its early-career researchers. The event, held at the end of April at Villa Eberhardt, focused on researchers who had received seed funding for their own research projects.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulm-university-honours-early-career-researchers-awards-ceremony-villa-eberhardt
  • Press release - 30/04/2026

    The white spot of inner ear research

    A new technique based on labelled sugar molecules is providing previously unknown insights into the inner ear. A study by the University of Konstanz and Charité-Universitätsmedizin Berlin shows that the cupula in the inner ear of zebrafish completely regenerates within approximately two months. These findings open up a new avenue for research into sudden hearing loss and acute disorders of the sense of balance.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/white-spot-inner-ear-research
  • Press release - 30/04/2026

    More collaboration, more impact: The Innovation Alliance Foundation Freiburg adopts a new resolution

    The University of Freiburg works closely with partners from various sectors including academia, business, politics and public administration through the Innovation Alliance Foundation Freiburg. The resolution that has been adopted reinforces the shared goal of establishing Freiburg as an attractive innovation hub with international appeal.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/more-collaboration-more-impact-innovation-alliance-foundation-freiburg-adopts-new-resolution
  • Press release - 28/04/2026

    Breast cancer brain metastases: patterns in immune cells could improve therapy decisions

    Brain metastases are among the most serious complications of breast cancer. Researchers at Heidelberg University, DKFZ, and UKHD have concluded an investigation of the immune cells in the brain tissue surrounding these breast cancer brain metastases. Their findings: spatial distribution patterns of immune cells are associated with prolonged patient survival. These findings could help to guide use of immunotherapies for breast cancer patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/breast-cancer-brain-metastases-patterns-immune-cells-could-improve-therapy-decisions
  • Press release - 24/04/2026

    New Medical Director of the Department of Nephrology

    Prof. Dr. Halbritter has served as the new Medical Director of the Department of Nephrology at the Medical Center – University of Freiburg since April 2026. With his expertise, he is enhancing care for patients with kidney disease: The goal is to prevent kidney failure through early diagnosis and the implementation of strategies to slow disease progression. For cases where kidney failure has already occurred, the focus is on organ replacement.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-medical-director-department-nephrology
  • Press release - 22/04/2026

    Turning four into two: How duplicated genomes become diploid again

    Genome duplication probably gave biodiversity a decisive evolutionary boost. A Chinese-German research team led by Axel Meyer from the University of Konstanz has now investigated the early phases of the process known as re-diploidization. The results show that the fusion of chromosome sets is asynchronous.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/turning-four-two-how-duplicated-genomes-become-diploid-again
  • Press release - 15/04/2026

    Why do women’s brains age differently?

    Estrogen does more than regulate reproduction — it helps brain cells handle stress. When levels decline after menopause, this ability is reduced, and these hormonal changes are believed to contribute to the increased risk of Alzheimer’s disease in women. MPI-IE researcher María José Pérez Jiménez has received the Klaus Tschira Boost Fund to investigate why — and whether these cellular responses can be restored.​

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-do-womens-brains-age-differently
  • Press release - 15/04/2026

    Electricity without cables or plugs

    How can you charge electric cars without plugging them into the power grid for hours on end? How can industrial robots be “refueled” during operation? And how does wireless energy transfer improve medical technology? These questions have occupied Prof. Nejila Parspour, Director of the Institute of Electrical Energy Conversion (IEW) at the University of Stuttgart, for more than twenty years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/electricity-without-cables-or-plugs
  • Press release - 14/04/2026

    T-helper cells switch to self-protection mode under prolonged stress

    Chronic infections cause long-term changes in key immune cells. T helper cells suppress their immune function to ensure their survival. New targets for vaccines and cancer immunotherapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/t-helper-cells-switch-self-protection-mode-under-prolonged-stress-1
  • Press release - 10/04/2026

    Lancet Countdown Europe: New Report on Health and Climate Change

    Europe’s dependence on fossil fuels is not only making the continent economically and politically vulnerable, it also has consequences for the population’s health. Growing air pollution, heat damage and the climate-related spread of infectious diseases are looming, warns the 2026 Europe Report of the Lancet Countdown on Health and Climate Change, which its co-directors are about to present to the public.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/lancet-countdown-europe-new-report-health-and-climate-change
  • Photoimmunotherapy - 09/04/2026 Zu sehen ist in einer Fluoreszenz-Aufnahme unter dem Mikroskop runde Ansammlungen in blauer Farbe, die die Zellkerne darstellen und rote Signale dicht daneben, die die Konjugate darstellen, all´ das vor schwarzem Hintergrund.

    Switching off tumours with light: how photons can be used to target prostate cancer

    Prostate cancer is the most common cancer among men in Germany. Relapses and the harsh side effects of traditional treatments remain a major challenge, even with advanced surgical techniques. At the University of Freiburg, Dr. Wolf is pioneering the development of photoimmunotherapy. Photoimmunotherapy combines light, antibodies and a specialised dye to precisely target tumour cells - simultaneously 'waking up' the immune system.

    https://www.gesundheitsindustrie-bw.de/en/article/news/switching-tumours-light-how-photons-can-be-used-target-prostate-cancer
  • Press release - 07/04/2026

    No soft drink before the massage

    How does sugar affect relaxation exercises? A new study carried out by researchers from the University of Konstanz provides revealing insights into the connection between blood glucose and the autonomic nervous system: The intake of sugar counteracts relaxation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-soft-drink-massage
  • Press release - 07/04/2026

    The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

    Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
  • Press release - 07/04/2026

    The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

    Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
  • Press release - 02/04/2026

    Pocket-sized biomedical technology to become smarter Volkswagen Foundation supports mobile health expert Professor Walter Karlen

    The Volkswagen Foundation is supporting the Ulm scientist Professor Walter Karlen with more than 940,000 euros from the funding initiative "Momentum - funding for first-time researchers". The engineer has headed the Institute of Biomedical Engineering at Ulm University since 2021. Karlen conducts research in the field of mobile health on so-called Medicine Wearables, i.e. portable technology for recording health data.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/pocket-sized-biomedical-technology-become-smarter-volkswagen-foundation-supports-mobile-health-expert-professor-walter-karlen
  • Press release - 01/04/2026

    Digital Assistance System Designed to Prevent Recurrent Heart Disease

    Women who have experienced a stroke or heart attack are at a higher risk of mortality than men. Fraunhofer researchers want to improve gender-specific aftercare with a customized assistance system – thus helping to prevent further heart disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-assistance-system-designed-prevent-recurrent-heart-disease
  • Press release - 31/03/2026

    First steps towards cell therapy for brain disorders

    Researchers in Freiburg have found a way to selectively replace defective immune cells in the blood vessels of the brain using an animal model. This is an important first step towards cell therapies for Alzheimer’s disease and other brain disorders. The findings were recently published in the journal Nature Immunology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-steps-towards-cell-therapy-brain-disorders
  • Press release - 30/03/2026

    Ulm University funds projects on molecular quantum bits and digital diabetes research Research incubators focus on ideas outside the mainstream

    Creating scope for innovative projects from various disciplines: That is the aim of the research incubators at Ulm University. The aim is to initiate developments and ideas that could become relevant research areas for the University. In the current call for proposals, the jury has selected two interdisciplinary projects on quantum chemistry and digital, sensor-based diabetes research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulm-university-funds-projects-molecular-quantum-bits-and-digital-diabetes-research-research-incubators-focus-ideas-outside-mains
  • Proof-of-concept study of organoid technology - 26/03/2026 Smiling man with glasses wearing a white lab coat.

    Can organoids improve the treatment of pancreatic cancer?

    A clinical trial called UNITEPANC is exploring whether organoid-based approaches can improve the treatment of pancreatic cancer. BIOPRO Baden-Württemberg spoke with the study’s principal investigator and pancreatic cancer specialist, Prof. Dr. Thomas Seufferlein of University Hospital Ulm, to discuss the disease more broadly along with the specific aims of the trial. The interview was conducted by Walter Pytlik on behalf of BIOPRO.

    https://www.gesundheitsindustrie-bw.de/en/article/news/can-organoids-improve-treatment-pancreatic-cancer

Page 1 / 22

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search